Personalized assessment of hyperuricemia probability in metabolic dysfunction-associated steatotic liver disease: construction and multicenter validation of a clinical nomogram

Abstract Background Metabolic dysfunction-associated steatotic liver disease is increasingly recognized as a precursor to secondary hyperuricemia, significantly exacerbating metabolic burden. However, reliable tools for early risk stratification in MASLD patients remain limited. This study aimed to...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yahui Wu, Jinsheng Wang, Yixiang Xing, Min Kang, Xiaoqing Yuan, Yun Shen
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2026-05-01
Ráidu:	BMC Gastroenterology
Fáttát:	Metabolic dysfunction-associated steatotic liver disease Hyperuricemia Machine learning Nomogram TyG index External validation
Liŋkkat:	https://doi.org/10.1186/s12876-026-04844-z
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!